AZTA

Azenta, Inc. [AZTA] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

AZTA Stock Summary

Top 10 Correlated ETFs

AZTA


Top 10 Correlated Stocks

AZTA


In the News

10:05 29 Mar 2024 AZTA

Azenta, Inc. (AZTA) Q1 2024 Earnings Call Transcript

Azenta, Inc. (AZTA) Q1 2024 Earnings Call Transcript

10:46 29 Mar 2024 AZTA

5 medical stocks growing earnings by triple digits

While most of the market focuses on hyper-growth technology stocks rewarded by Wall Street as long as they mention the word "artificial intelligence" in their earnings calls, the reality is that the fundamentals now favor other (safer) areas of the economy.

06:35 29 Mar 2024 AZTA

Final Trade: DISH, GLD, EWJ and AZTA

The final trades of the day with the 'Fast Money' traders.

11:17 29 Mar 2024 AZTA

3 Stocks to Watch After Impressive Earnings Beats

In a somewhat quiet earnings lineup this week, several stocks stand out after posting strong quarterly results on Monday.

08:36 29 Mar 2024 AZTA

Azenta, Inc. (AZTA) Q4 2023 Earnings Call Transcript

Azenta, Inc. (NASDAQ:AZTA ) Q4 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Sara Silverman - Head of IR Steve Schwartz - President and CEO Herman Cueto - CFO Conference Call Participants David Saxon - Needham Jacob Johnson - Stephens Andrew Cooper - Raymond James Paul Knight - KeyBanc Vijay Kumar - Evercore ISI Yuan Zhi - B. Riley Operator Thank you, and welcome to the Azenta Q4 2023 Financial Results.

05:01 29 Mar 2024 AZTA

Azenta shares jump on Q4 results, buyback plans

Shares of Azenta Inc. AZTA, +0.59% jumped 11.9% after hours on Monday after the life-sciences company reported fourth-quarter results that beat expectations and announced plans to buy back an extra $500 million in stock in fiscal 2024. The company — whose products and services help researchers store, handle and process chemical and biological samples — reported net income of $3.4 million, or 6 cents a share, compared with a loss of $20.8 million, or 28 cents a share, in the same quarter last year.

03:07 29 Mar 2024 AZTA

Azenta: Life Science Play Suffers A Bad Diagnosis

Azenta, Inc., formerly Brooks Automation, sold its semiconductor business and subsequently became a pure play life science business. Azenta's shares have declined significantly and its valuation is still supported by net cash holdings. However, Azenta is not profitable, making it difficult to be optimistic about its shares.

08:55 29 Mar 2024 AZTA

You Can't Control Activist Investors, but You Can Control What You Do About Them

Having activist investors at a company can lead to big changes. Azenta is dealing with an activist's call for better performance as it puts a giant cash hoard to work.

09:04 29 Mar 2024 AZTA

Activist Politan Capital engages with Azenta. Here's how the firm may boost shareholder value

Azenta is sitting on a pile of cash, and shareholders will want to know the company's plans for the money.

04:05 29 Mar 2024 AZTA

Azenta to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

BURLINGTON, Mass. , Sept. 8, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Morgan Stanley 21st Annual Global Healthcare Conference in New York, NY, on Wednesday, September 13, 2023, which includes a presentation beginning at 2:55 pm ET.

AZTA Financial details

Company Rating
Neutral
Market Cap
3.31B
Income
-15.81M
Revenue
641.02M
Book val./share
43.09
Cash/share
17.35
Dividend
-
Dividend %
-
Employees
3.5K
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
-340.69
Forward P/E
-172.23
PEG
-41.48
P/S
5.42
P/B
1.52
P/C
3.47
P/FCF
-164.29
Quick Ratio
5.57
Current Ratio
6.73
Debt / Equity
0.03
LT Debt / Equity
0.03
-
-
EPS (TTM)
-0.27
EPS next Y
-0.35
EPS next Q
0.09
EPS this Y
46.67%
EPS next Y
29.33%
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-3.18%
Revenue Q/Q
-10.47%
EPS Q/Q
-566.67%
-
-
-
-
SMA20
-8.82%
SMA50
-9.2%
SMA100
24.93%
Inst Own
72.59%
Inst Trans
0.78%
ROA
-
ROE
-
ROC
-0.03%
Gross Margin
40%
Oper. Margin
-13%
Profit Margin
-2%
Payout
-
Shs Outstand
55.77M
Shs Float
54.69M
-
-
-
-
Target Price
70
52W Range
36.01-69.16
52W High
-12.64%
52W Low
+67.44%
RSI
44.12
Rel Volume
0.87
Avg Volume
420.86K
Volume
367.33K
Perf Week
2.69%
Perf Month
-8.12%
Perf Quarter
21.78%
Perf Half Y
25.85%
-
-
-
-
Beta
1.539
-
-
Volatility
0.74%, 3%
Prev Close
1.43%
Price
60.28
Change
2.57%

AZTA Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-09-30

Metric History 2019-09-302020-09-302021-09-302022-09-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
10.8612.26.927.4210.04
Net income per share
0.140.88-0.39-0.15-0.22
Operating cash flow per share
1.260.512.02-6.220.26
Free cash flow per share
0.93-0.031.31-7.26-0.33
Cash per share
4.664.023.0620.9615.36
Book value per share
15.8316.517.8544.9138.25
Tangible book value per share
5.556.719.0235.6721.97
Share holders equity per share
15.8316.517.8544.9138.25
Interest debt per share
1.021.163.30.811.07
Market cap
2.67B3.4B7.6B3.21B3.33B
Enterprise value
2.42B3.19B7.46B2.6B2.71B
P/E ratio
269.5552.47-263.17-284.43-233.24
Price to sales ratio
3.413.7914.795.785
POCF ratio
29.3389.8650.7-6.89190.12
PFCF ratio
39.77-1.65K78.28-5.91-151.52
P/B Ratio
2.342.85.730.951.31
PTB ratio
2.342.85.730.951.31
EV to sales
3.093.5514.534.684.07
Enterprise value over EBITDA
23.4822.03397.3552.3465.73
EV to operating cash flow
26.5784.2349.81-5.58154.76
EV to free cash flow
36.03-1.55K76.91-4.79-123.34
Earnings yield
00.02000
Free cash flow yield
0.0300.01-0.17-0.01
Debt to equity
0.040.070.180.020.03
Debt to assets
0.030.050.130.020.02
Net debt to EBITDA
-2.43-1.47-7.06-12.25-15.02
Current ratio
2.373.082.2510.676.73
Interest coverage
2.0926.65-22.85-0.870
Income quality
0.210.581.35-0.22-1.23
Dividend Yield
0.010.01000
Payout ratio
2.920.46-1.03-0.660
Sales general and administrative to revenue
00000
Research and developement to revenue
0.070.070.040.050.05
Intangibles to total assets
0.490.460.360.190.37
Capex to operating cash flow
-0.26-1.05-0.350.17-2.25
Capex to revenue
-0.03-0.04-0.1-0.14-0.06
Capex to depreciation
-0.44-0.61-0.81-1.44-0.46
Stock based compensation to revenue
0.030.020.050.020.01
Graham number
6.9918.0912.512.3413.61
ROIC
0.040.05-0.020-0.01
Return on tangible assets
0.010.08-0.020-0.01
Graham Net
1.842.02-1.9718.4612.8
Working capital
375.21M438.34M432.28M2.23B1.21B
Tangible asset value
399.52M493.75M669.44M2.67B1.46B
Net current asset value
270.44M303.94M283.19M2.11B1.07B
Invested capital
0.040.070.180.020.03
Average receivables
146.3M177.47M154.08M141.82M160.15M
Average payables
57.66M60.6M52.06M40.51M37.23M
Average inventory
98.22M107.14M87.62M72.97M106.87M
Days sales outstanding
77.876.5985.18107.685.91
Days payables outstanding
46.6443.5857.2947.0432.51
Days of inventory on hand
78.0481.0381.68104.11116.42
Receivables turnover
4.694.774.293.394.25
Payables turnover
7.838.386.377.7611.23
Inventory turnover
4.684.54.473.513.14
ROE
0.010.05-0.020-0.01
Capex per share
-0.33-0.54-0.71-1.03-0.6

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q1

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
2.462.242.622.892.72
Net income per share
-0.15-0.03-0.020.06-0.28
Operating cash flow per share
-0.37-0.180.260.670.47
Free cash flow per share
-0.55-0.320.150.50.26
Cash per share
15.5917.817.7217.0817.35
Book value per share
39.5843.6242.9442.5243.09
Tangible book value per share
24.5826.8325.524.4323.86
Share holders equity per share
39.5843.6242.9442.5243.09
Interest debt per share
0.831.051.011.081.41
Market cap
4.22B2.96B2.96B2.99B3.69B
Enterprise value
3.67B2.35B2.29B2.37B3.06B
P/E ratio
-93.98-371.83-503.57221.59-58.73
Price to sales ratio
23.6819.9517.8417.3623.94
POCF ratio
-156.31-243.73176.874.95139.76
PFCF ratio
-105.95-140.93320.63100.74254.55
P/B Ratio
1.471.021.091.181.51
PTB ratio
1.471.021.091.181.51
EV to sales
20.5615.8413.813.7719.81
Enterprise value over EBITDA
-255.23-112.51134.35137.1-1.19K
EV to operating cash flow
-135.74-193.5136.759.46115.68
EV to free cash flow
-92.01-111.89247.9179.92210.69
Earnings yield
00000
Free cash flow yield
-0.01-0.0100.010
Debt to equity
0.020.020.020.030.03
Debt to assets
0.020.020.020.020.03
Net debt to EBITDA
38.6829.2-39.41-35.73247.55
Current ratio
6.517.467.426.735.87
Interest coverage
-609.84-8.7805.030
Income quality
2.42.47-11.3911.83-1.68
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
0.040.060.050.050.06
Intangibles to total assets
0.330.340.360.370.39
Capex to operating cash flow
0.480.73-0.45-0.26-0.45
Capex to revenue
-0.07-0.06-0.05-0.06-0.08
Capex to depreciation
-0.64-0.4-0.35-0.46-0.55
Stock based compensation to revenue
0.010.030.0200.02
Graham number
11.745.434.737.3616.4
ROIC
-0.01000-0.01
Return on tangible assets
-0.01000-0.01
Graham Net
12.8815.4915.3114.2313.83
Working capital
1.37B1.37B1.31B1.21B1.15B
Tangible asset value
1.78B1.78B1.62B1.46B1.35B
Net current asset value
1.2B1.23B1.16B1.07B1B
Invested capital
0.020.020.020.030.03
Average receivables
182.84M184.94M165.49M159.78M156.23M
Average payables
46.96M50.28M41.65M36.89M38.02M
Average inventory
115.74M148.33M146.41M135.15M127.69M
Days sales outstanding
101.88101.8688.4181.7490.94
Days payables outstanding
47.5942.8534.9130.8839.02
Days of inventory on hand
125.69142.55130.58110.6123.34
Receivables turnover
0.880.881.021.10.99
Payables turnover
1.892.12.582.912.31
Inventory turnover
0.720.630.690.810.73
ROE
0000-0.01
Capex per share
-0.18-0.13-0.12-0.17-0.21

AZTA Frequently Asked Questions

What is Azenta, Inc. stock symbol ?

Azenta, Inc. is a US stock , located in Chelmsford of Ma and trading under the symbol AZTA

Is Azenta, Inc. buy or a sell ?

2 stock analysts have 2 predictions with a medium analyst target price of $70. The lowest prediction is $62 and the highest is $78

What is AZTA stock prediction ?

What is Azenta, Inc. stock quote today ?

Azenta, Inc. stock price is $60.28 today.

Is Azenta, Inc. stock public?

Yes, Azenta, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks